Pharmaceutical legislation update subscription service

Published: 2-Jul-2021 Featured companies: NSF
Regulatory

Sign up for NSF’s September start date

Stay on top of your CPD with our Pharmaceutical Legislation Update Subscription Service. Access 12 months of regulatory updates and changes to legislation that have the potential to impact the manufacture and distribution of medicinal/drug products.

Our regulatory expert Pete Gough will provide a live virtual Q&A each quarter to complement the recorded sessions you will receive.

Programme

  • Q3 Full update available from Sep. 10, 2021
  • Q3 Live QA on Sep. 24 | 13:00 to 15:00 UK time
  • Q4 Interim update available from Dec. 1, 2021
  • Q4 Live Q&A on Dec. 10 | 13:00 to 14:00 UK time
  • Q1 Full update available from Feb. 11, 2022
  • Q1 Live Q&A on Mar. 3 | 13:00 to 15:00 UK time
  • Q2 Interim update available from May 9, 2022
  • Q2 Live Q&A on May 19 | 13:00 to 14:00 UK time

This service is Royal Society of Chemistry approved as suitable for its members’ continuing professional development (CPD).

About Pete Gough

Pete Gough - Peter has over 45 years’ experience in the pharmaceutical industry and for nearly 20 years has been responsible for advising senior management regarding changes to pharmaceutical legislation and guidance.

Learn more and sign up for the service

Featured companies

Founded in 1944, NSF’s mission is to protect and improve global human health. NSF, Pharmaceutical Services provides a comprehensive range of independent, third-party...
See more

You may also like

Regulatory

NSF International launches two water fitting accreditations

Read more
New REG4 Accreditations to Help Water Fittings Suppliers Rapidly Deliver Products to Market

Trending Articles

  1. Accelerating and enhancing toxicology assessments Infographic guides users through ToxHQ’s speedy assessment features
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Merck jumps on the GLP-1 therapeutic bandwagon by licensing Hansoh Pharma's HS-10535 Merck will be responsible for the development, manufacture and commercialisation of the investigational preclinical oral GLP-1 receptor agonist
  3. Bayer's acoramidis recommended for approval by the EMA's CHMP for cardiomyopathy The orally administered transthyretin (TTR) stabiliser is suitable for patients with transthyretin amyloid cardiomyopathy, demonstrating at least a 90% TTR stabilisation capacity and a reduction in cardiovascular-related hospitalisations
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    Why quality control should be intimately combined with sterile product development, manufacturing and the overall product supply chain With sponsor companies increasingly needing to create and launch differentiated, stable, usable and safe injectable treatments for patients, experts at ten23 health are keen to promote the importance of integrating development and/or manufacturing with quality control services
  5. The right validation model: practical considerations and applications It is widely accepted that validation in the life sciences industry follows a lifecycle model (1,2). What is not always clear is the specific model — or models — to follow and how to navigate through them in the real world. Hurdles to overcome include the specific deliverables that make up that model and how they change during the various interactions along the validation journey

Relevant companies

See more

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Regulatory

NSF International launches two water fitting accreditations

New REG4 Accreditations to Help Water Fittings Suppliers Rapidly Deliver Products to Market
Regulatory

2022 Pharma Training Courses from NSF

Start your year right and keep your goals on track with NSF’s training and education. NSF's pharma training and education programs focus on changing behaviours at both an individual and organisation-wide level
Regulatory

NSF explains why you might need a remediation program

The team at NSF explores why remediation projects are needed, the traits of successful programs and what to do to ensure success in your remediation efforts
Manufacturing

Big names announced for leading Pharma and Cleanroom conference

The Cleanroom Technology Conference and Manufacturing Chemist Live collaboration will take place on the 10-11 November. Delegate tickets are currently available
Regulatory

White paper: Streamlining Pharma Operations in the Wake of COVID-19

COVID-19 is shedding further light on pharmaceutical sourcing strategies and their inherent complexity, explains Jim Morris
Regulatory

Free webinar: Update on EMA and FDA’s approach to tackling drug shortages

The webinar will be hosted on 8 September, 2020 – 1pm BST
Regulatory

New edition of NSF’s Health Sciences Journal now live

The new Health Sciences Journal focuses on hope and optimism and is available to download
Subscribe now